156 related articles for article (PubMed ID: 11815455)
21. Tissue-specific effects of sulfonylureas: lessons from studies of cloned K(ATP) channels.
Ashcroft FM; Gribble FM
J Diabetes Complications; 2000; 14(4):192-6. PubMed ID: 11004427
[TBL] [Abstract][Full Text] [Related]
22. A novel enhancer of insulinotrophic action by high glucose (JTT-608) stimulates insulin secretion from pancreatic beta-cells via a new cellular mechanism.
Itabashi N; Okada K; Muto S; Fujita N; Ohta T; Miyazaki Ji ; Asano Y; Saito T
J Pharmacol Exp Ther; 2001 Jun; 297(3):953-60. PubMed ID: 11356916
[TBL] [Abstract][Full Text] [Related]
23. Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line.
Sturgess NC; Kozlowski RZ; Carrington CA; Hales CN; Ashford ML
Br J Pharmacol; 1988 Sep; 95(1):83-94. PubMed ID: 3146398
[TBL] [Abstract][Full Text] [Related]
24. Triggering and amplifying pathways of regulation of insulin secretion by glucose.
Henquin JC
Diabetes; 2000 Nov; 49(11):1751-60. PubMed ID: 11078440
[TBL] [Abstract][Full Text] [Related]
25. Insulin secretion and its modulation by antiarrhythmic and sulfonylurea drugs.
Horie M; Ishida-Takahashi A; Ai T; Nishimoto T; Tsuura Y; Ishida H; Seino Y; Sasayama S
Cardiovasc Res; 1997 Apr; 34(1):69-72. PubMed ID: 9217874
[TBL] [Abstract][Full Text] [Related]
26. Sulfonylurea sensitivity of adenosine triphosphate-sensitive potassium channels from beta cells and extrapancreatic tissues.
Gribble FM; Ashcroft FM
Metabolism; 2000 Oct; 49(10 Suppl 2):3-6. PubMed ID: 11078468
[TBL] [Abstract][Full Text] [Related]
27. Ion channels in secretory granules of the pancreas and their role in exocytosis and release of secretory proteins.
Thévenod F
Am J Physiol Cell Physiol; 2002 Sep; 283(3):C651-72. PubMed ID: 12176723
[TBL] [Abstract][Full Text] [Related]
28. [Molecular mechanisms of insulin secretion].
Bataille D
Diabetes Metab; 2002 Dec; 28(6 Suppl):4S7-13. PubMed ID: 12703060
[TBL] [Abstract][Full Text] [Related]
29. Molecular action of sulphonylureas on KATP channels: a real partnership between drugs and nucleotides.
de Wet H; Proks P
Biochem Soc Trans; 2015 Oct; 43(5):901-7. PubMed ID: 26517901
[TBL] [Abstract][Full Text] [Related]
30. Glucose activates both K(ATP) channel-dependent and K(ATP) channel-independent signaling pathways in human islets.
Straub SG; James RF; Dunne MJ; Sharp GW
Diabetes; 1998 May; 47(5):758-63. PubMed ID: 9588447
[TBL] [Abstract][Full Text] [Related]
31. Metabolic regulation of the K(ATP) and a maxi-K(V) channel in the insulin-secreting RINm5F cell.
Ribalet B; Eddlestone GT; Ciani S
J Gen Physiol; 1988 Aug; 92(2):219-37. PubMed ID: 3049931
[TBL] [Abstract][Full Text] [Related]
32. Fast and cAMP-sensitive mode of Ca(2+)-dependent exocytosis in pancreatic beta-cells.
Kasai H; Suzuki T; Liu TT; Kishimoto T; Takahashi N
Diabetes; 2002 Feb; 51 Suppl 1():S19-24. PubMed ID: 11815452
[TBL] [Abstract][Full Text] [Related]
33. Sulfonylurea binding to a low-affinity site inhibits the Na/K-ATPase and the KATP channel in insulin-secreting cells.
Ribalet B; Mirell CJ; Johnson DG; Levin SR
J Gen Physiol; 1996 Feb; 107(2):231-41. PubMed ID: 8833343
[TBL] [Abstract][Full Text] [Related]
34. Sulfonylurea receptors and mechanism of sulfonylurea action.
Panten U; Schwanstecher M; Schwanstecher C
Exp Clin Endocrinol Diabetes; 1996; 104(1):1-9. PubMed ID: 8750563
[TBL] [Abstract][Full Text] [Related]
35. Regulation of glucagon secretion at low glucose concentrations: evidence for adenosine triphosphate-sensitive potassium channel involvement.
Muñoz A; Hu M; Hussain K; Bryan J; Aguilar-Bryan L; Rajan AS
Endocrinology; 2005 Dec; 146(12):5514-21. PubMed ID: 16123162
[TBL] [Abstract][Full Text] [Related]
36. Intracellular targets for antidiabetic sulfonylureas and potassium channel openers.
Szewczyk A
Biochem Pharmacol; 1997 Nov; 54(9):961-5. PubMed ID: 9374415
[TBL] [Abstract][Full Text] [Related]
37. Increased uncoupling protein-2 levels in beta-cells are associated with impaired glucose-stimulated insulin secretion: mechanism of action.
Chan CB; De Leo D; Joseph JW; McQuaid TS; Ha XF; Xu F; Tsushima RG; Pennefather PS; Salapatek AM; Wheeler MB
Diabetes; 2001 Jun; 50(6):1302-10. PubMed ID: 11375330
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets.
Schwanstecher M; Mnner K; Panten U
Pharmacology; 1994 Aug; 49(2):105-11. PubMed ID: 7972319
[TBL] [Abstract][Full Text] [Related]
39. Glucose triggers protein kinase A-dependent insulin secretion in mouse pancreatic islets through activation of the K+ATP channel-dependent pathway.
Thams P; Anwar MR; Capito K
Eur J Endocrinol; 2005 Apr; 152(4):671-7. PubMed ID: 15817925
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular effects of sulphonylureas: role of K(ATP) channels.
Howes LG
Diabetes Obes Metab; 2000 Apr; 2(2):67-73. PubMed ID: 11220526
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
